Praxis Precision Medicines Inc (PRAX)

Praxis Precision Medicines Inc 주식(PRAX)의 최신 뉴스

Regenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research

Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Wall Street Analysts See a 144.74% Upside in Praxis Precision Medicines (PRAX): Can the Stock Really Move This High?

Zacks Investment Research

Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting

GlobeNewswire Inc.

Praxis Precision Medicines (PRAX) Upgraded to Buy: Here's Why

Zacks Investment Research

Praxis Precision Medicines to Participate in Upcoming April Conferences

GlobeNewswire Inc.

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates

Zacks Investment Research

Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering

GlobeNewswire Inc.

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

GlobeNewswire Inc.

Praxis (PRAX) Surges on Positive Epilepsy Study Results

Zacks Investment Research

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday

Benzinga

Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients

GlobeNewswire Inc.

Praxis Precision Medicines to Host PRAX-628 Program Update

GlobeNewswire Inc.

What Makes Praxis Precision Medicines, Inc. (PRAX) a Strong Momentum Stock: Buy Now?

Zacks Investment Research

Wall Street Analysts Think Praxis Precision Medicines, Inc. (PRAX) Could Surge 134.35%: Read This Before Placing a Bet

Zacks Investment Research

Praxis Precision Medicines, Inc. (PRAX) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research

Praxis Precision Medicines to Participate in TD Cowen’s 44th Annual Health Care Conference

GlobeNewswire Inc.

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month

Benzinga

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

GlobeNewswire Inc.

Praxis Precision Medicines, Inc. (PRAX) Upgraded to Strong Buy: Here's What You Should Know

Zacks Investment Research

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Praxis Precision Medicines, Inc. (PRAX) Just Flashed Golden Cross Signal: Do You Buy?

Zacks Investment Research

Praxis Precision Medicines to Showcase Largest Pipeline of Precision Epilepsy Programs and Breadth of Commitment to Epilepsy Treatments at Upcoming Meetings

GlobeNewswire Inc.

Praxis Precision Medicines to Present at the Piper Sandler 35th Annual Healthcare Conference

GlobeNewswire Inc.

Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental Epilepsies

GlobeNewswire Inc.

Praxis Precision Medicines, Inc. (PRAX) Loses -32.03% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks Investment Research